Insider Selling: Church & Dwight (NYSE:CHD) EVP Sells 21,970 Shares of Company Stock

Key Points

• EVP Surabhi Pokhriyal sold 21,970 Church & Dwight shares for about $2.44 million at an average price of $111.23, reducing her reported holdings by 96.08% to 896 shares.
• Church & Dwight beat quarterly estimates, reporting EPS of $0.92 versus $0.90 expected and revenue of $1.60 billion, up 1% year over year. The company also declared a quarterly dividend of $0.3075 per share.
• Analyst opinions were mixed: eight rated the stock Buy, eight Hold, and one Sell, with a consensus rating of Hold and an average target price of $108.44.

Church & Dwight Co., Inc. (NYSE:CHD - Get Free Report) EVP Surabhi Pokhriyal sold 21,970 shares of the stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $111.23, for a total value of $2,443,723.10. Following the completion of the sale, the executive vice president owned 896 shares of the company's stock, valued at approximately $99,662.08. This trade represents a 96.08% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Church & Dwight Stock Down 0.4%

Shares of CHD stock traded down $0.40 during trading hours on Thursday, reaching $111.62. 1,001,557 shares of the company's stock were exchanged, compared to its average volume of 2,064,561. Church & Dwight Co., Inc. has a 1 year low of $81.49 and a 1 year high of $114.64. The stock has a market cap of $26.35 billion, a PE ratio of 34.35, a PEG ratio of 3.96 and a beta of 0.45. The company has a current ratio of 0.96, a quick ratio of 0.62 and a debt-to-equity ratio of 0.40. The stock's fifty day moving average price is $100.83 and its two-hundred day moving average price is $98.45.

Church & Dwight (NYSE:CHD - Get Free Report) last announced its quarterly earnings data on Friday, October 30th. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.90 by $0.02. Church & Dwight had a net margin of 12.41% and a return on equity of 20.28%. The firm had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same period last year, the firm posted $0.81 EPS. Church & Dwight's revenue was up 1.0% on a year-over-year basis. Research analysts predict that Church & Dwight Co., Inc. will post 3.77 EPS for the current year.

Church & Dwight Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 1st. Stockholders of record on Friday, November 13th will be issued a $0.3075 dividend. This represents a $1.23 annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend is Friday, November 13th. Church & Dwight's payout ratio is 37.85%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on CHD. Wells Fargo & Company reaffirmed an "overweight" rating and set a $115.00 target price (up from $105.00) on shares of Church & Dwight in a report on Monday, November 2nd. Weiss Ratings reissued a "hold (c+)" rating on shares of Church & Dwight in a report on Wednesday, October 14th. Royal Bank Of Canada upped their price objective on Church & Dwight from $114.00 to $115.00 and gave the stock an "outperform" rating in a research report on Monday, August 3rd. JPMorgan Chase & Co. lifted their target price on shares of Church & Dwight from $105.00 to $109.00 and gave the company a "neutral" rating in a report on Monday, November 2nd. Finally, Oppenheimer boosted their target price on shares of Church & Dwight from $115.00 to $120.00 and gave the company an "outperform" rating in a research note on Wednesday, October 28th. Eight equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Church & Dwight currently has an average rating of "Hold" and a consensus target price of $108.44.

Institutional Trading of Church & Dwight

Institutional investors and hedge funds have recently modified their holdings of the stock. BlackRock Inc. purchased a new position in shares of Church & Dwight in the second quarter valued at approximately $2,174,535,000. Allspring Global Investments Holdings LLC boosted its stake in Church & Dwight by 51.2% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 5,050,105 shares of the company's stock worth $468,902,000 after purchasing an additional 1,709,090 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Church & Dwight by 18.5% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,925,749 shares of the company's stock worth $283,447,000 after purchasing an additional 457,445 shares during the last quarter. Bank of America Corp DE grew its holdings in shares of Church & Dwight by 28.9% during the first quarter. Bank of America Corp DE now owns 2,548,871 shares of the company's stock worth $237,861,000 after buying an additional 572,085 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in shares of Church & Dwight by 3.1% during the first quarter. Dimensional Fund Advisors LP now owns 2,170,890 shares of the company's stock worth $202,597,000 after buying an additional 64,803 shares in the last quarter. Hedge funds and other institutional investors own 86.60% of the company's stock.

About Church & Dwight

Church & Dwight is a consumer products company whose history traces to 1846, when John Dwight and Austin Church began producing baking soda. The company is best known for its ARM & HAMMER brand and sells household, personal care, and specialty products under a portfolio of owned brands. Its products include laundry detergents and cleaners, oral care items, cat litter, deodorants, condoms, pregnancy and ovulation tests, hair-removal products, and water flossers. Brands include OxiClean, Trojan, First Response, Nair, Waterpik, and TheraBreath, alongside ARM & HAMMER.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.